Transient Ischemic Attack News and Research

RSS
A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.
Study explores differences in neuroimaging utilization for stroke from population perspective

Study explores differences in neuroimaging utilization for stroke from population perspective

Mini-stroke should immediately be treated with aspirin, recommend researchers

Mini-stroke should immediately be treated with aspirin, recommend researchers

Important signs, symptoms of stroke that everyone should know

Important signs, symptoms of stroke that everyone should know

Novel anticoagulants on ‘as-needed basis’ could be safe alternative to lowering stroke risk

Novel anticoagulants on ‘as-needed basis’ could be safe alternative to lowering stroke risk

Structured transitional stroke care could decrease hospital readmission rates

Structured transitional stroke care could decrease hospital readmission rates

Stenting and surgery equally effective at lowering long-term risk of stroke

Stenting and surgery equally effective at lowering long-term risk of stroke

Pioglitazone drug may prevent recurrent stroke and heart attacks

Pioglitazone drug may prevent recurrent stroke and heart attacks

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New MRI-based technology could help identify patients at risk of recurrent stroke

New MRI-based technology could help identify patients at risk of recurrent stroke

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Use of balloon-expandable stent compared with medical therapy increases stroke risk

Use of balloon-expandable stent compared with medical therapy increases stroke risk

Transcatheter MitraClip system safe, effective for valve repair treatment

Transcatheter MitraClip system safe, effective for valve repair treatment

New technology can help identify patients at risk of second stroke

New technology can help identify patients at risk of second stroke

Closer monitoring needed to help prevent repeat strokes

Closer monitoring needed to help prevent repeat strokes

'Win-win' program provides better care to stroke patients, reduces hospital bed days

'Win-win' program provides better care to stroke patients, reduces hospital bed days

Large number of Canadian stroke patients not getting help to get back to active life

Large number of Canadian stroke patients not getting help to get back to active life

Protective effects of ischemic preconditioning on focal cerebral infarction linked with upregulation of VEGF

Protective effects of ischemic preconditioning on focal cerebral infarction linked with upregulation of VEGF

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo acquires worldwide rights to Zogenix' sumatriptan injection